Topics

Latest "Acetylon Pharmaceuticals" News Stories

17:29 EST 11th December 2019 | BioPortfolio

Here are the most relevant search results for "Acetylon Pharmaceuticals" found in our extensive news archives from over 250 global news sources.

More Information about Acetylon Pharmaceuticals on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Acetylon Pharmaceuticals for you to read. Along with our medical data and news we also list Acetylon Pharmaceuticals Clinical Trials, which are updated daily. BioPortfolio also has a large database of Acetylon Pharmaceuticals Companies for you to search.

Showing "Acetylon Pharmaceuticals" News Articles 1–25 of 5,400+

Wednesday 11th December 2019

Global Oncology AntiCancer Drugs Market Research Report 20122024 [Report Updated: 26052019] Prices from USD $1778

SummaryThe global Oncology AntiCancer Drugs market will reach xxx Million USD in 2019 with CAGR xx% 20192024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.Based on products type, the report descr...


Verge Genomics Announces the Addition of Two Renowned Neuroscience Drug Development Industry Experts to its Advisory Board

Verge Genomics, a drug discovery company developing therapeutics for neurological diseases, announced today the appointment of Dr. Thomas Large and Dr. James Summers to its scientific advisory board. SAN FRANCISCO (PRWEB) December 11, 2019 Verge Genomics, a drug discovery company developing therapies for neurological diseases by integrating a unique all-in-human genomic platform with machine lear...

Mediaplanet and Actress Glenn Close Team Up for Mental Health Awareness

Mediaplanet’s Mental Health campaign, found within USA TODAY and online, helps shed light on the pressing need for more mental health support in the United States. NEW YORK (PRWEB) December 11, 2019 Mediaplanet recently announced the launch of the most recent edition of the “Mental Health” campaign. This campaign will educate readers on the importance of destigmatizing mental health and ens...


Dry Powder Inhaler Devices Device Pipeline Study Analysis of Devices under Development, Companies, Developments and Outlook [Published by VPA Research] Prices from USD $1583

Global Dry Powder Inhaler Devices market is one of the largely focused segments of medical devices worldwide. The global Dry Powder Inhaler Devices industry is estimated to be around $0.7 billion in 2019 driven by increasing demand from Capsule based devices, Blister based devices, Cartridge based devices. The 2019 Dry Powder Inhaler Devices pipeline is characterized by presence of 19 companies, a...

AMAG Pharmaceuticals Inc AMAG Financial and Strategic SWOT Analysis Review [Published by Global Data] Prices from USD $110

AMAG Pharmaceuticals Inc AMAG Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augm...

Fresenius Kabi AG Strategic SWOT Analysis Review [Published by Global Data] Prices from USD $110

Fresenius Kabi AG Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.This uptotheminute company report will help you to formulate strategies to drive your business b...

Arcturus Therapeutics to Present at the Investor Summit on December 17th in Philadelphia.

PHILADELPHIA, PA / ACCESSWIRE / December 11, 2019 / Arcturus Therapeutics (ARCT), will be presenting at this year's Investor Summit on December 17th in Philadelphia. The Investor Summit will take place at Hotel Monaco, featuring 30 companies and over 200 institutional and retail investors. About Arcturus Therapeutics Holdings, Inc. Founded in 2013 and based in San Diego, California, Arcturu...

TFF Pharmaceuticals to Meet with Investors and Commercial Partners in San Francisco during the JP Morgan Healthcare Conference

TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced that it will be meeting with investors and commercial partners from January 13 to January 16, 2020 in San Francisco, concurrent with the JP Morgan Healthcare Confe...

Pyxis Oncology Appoints Lara Sullivan, M.D. as Chief Executive Officer and Director

Pyxis Oncology, an immuno-oncology company focused on developing a new family of antibody-based immunotherapies derived from novel insights into the biology of the tumor microenvironment, today announced the appointment of Lara Sullivan, M.D. as Chief Executive Officer and Director. She succeeds Longwood General Partner and founding Chief Executive Officer, David Steinberg, who assumes the role o...

Arrowhead Pharmaceuticals Files IND for Phase 1b Study of ARO-HIF2 for Treatment of Clear Cell Renal Cell Carcinoma

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it has submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for a Phase 1b adaptive dose-finding clinical study of ARO-HIF2, the company’s investigational RNA interference (RNAi) therapeutic being developed as a treatment for patients with clear cell renal cell carcinoma (ccRCC)....

Sunesis Pharmaceuticals (SNSS) Investor Presentation - Slideshow

Rocket Pharmaceuticals (RCKT) Presents At 2019 ASH Annual Meeting - Slideshow

Behind-The-Scenes Look At How A Drugmaker Is Causing ‘Insanely High’ Drug Levels In Nation’s Waterways

“It always bothered me pouring pharmaceuticals down the drain,” a former employee at generic-drug giant Mylan told Stat. Other public health news reports on the development of a potential E. coli vaccine, improving knee health by running marathons (yes), the toll on parents when teens are abusive and a look at why New York has the lowest suicide rates.

CStone announces enrollment target reached in the global Phase III VOYAGER trial of avapritinib in Chinese patients with third-line GIST

SUZHOU, China, Dec. 11, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone" or the "Company", HKEX: 2616) today announced that the on-going, global Phase III VOYAGER clinical trial of avapritinib, an investigational drug discovered by CStone's partner, Blueprint Medicines, has completed target patient enrollment in China. In addition, the VOYAGER trial's enrollment target has...

Omega Funds Raises $438 Million in Sixth Fund to Invest in the Future of Medicine

Omega Funds, a leading international investment firm focused on delivering impactful medicines to patients, today announced the closing of Omega Fund VI, L.P. (“Fund VI”), with $438 million in capital commitments. With Fund VI, the firm will continue to execute on its strategy of creating and investing in life sciences companies that target the most urgent medical needs. Since its inception i...

Global Alkyl Amine Market Research Report 20122024 [Report Updated: 21052019] Prices from USD $2050

SummaryThe global Alkyl Amine market will reach xxx Million USD in 2019 with CAGR xx% 20192024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.Based on products type, the report describes major pro...

Sanofi and Regeneron to simplify antibody partnership

Sanofi and Regeneron Pharmaceuticals have said the companies may transform their antibody partnership, which involves Kevzara (sarilumab) and Praluent (alirocumab)...Read More... The post Sanofi and Regeneron to simplify antibody partnership appeared first on Pharmaceutical Technology.

Alkermes, Inc. - 597260 - 12/02/2019

Finished Pharmaceuticals/Unapproved New Drug/Misbranded

Interstitial cystitis Market Review, Epidemiology And Market Forecast 2029 [Published by First View Insight] Prices from USD $3080

FirstView Market Insight "Interstitial Cystitis Market Review, Epidemiology and Market Forecast2029" provides in depth understanding of historical and forecasted epidemiology along with the detailed market insights. The report covers detailed information on the disease, treatment algorithm, existing treatment and upcoming treatment regimens, unmet needs, market drivers, market barriers, sales tre...

Global Pancreatitis Drugs Market Research Report 20122024 [Report Updated: 26052019] Prices from USD $1760

SummaryThe global Pancreatitis Drugs market will reach xxx Million USD in 2019 with CAGR xx% 20192024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.Based on products type, the report describes ma...

ADL Bionatur Solutions (ADL.) - CMO business driving growth

Edison Investment Research - Pharmaceuticals & healthcare - ADL Bionatur Solutions: ADL Bionatur Solutions’ (ADL-BS) 9M19 results show €2.16m adjusted EBITDA and 127% year-on-year operating revenue growth to €33.2m, driven by 195% growth in contract manufacturing (CMO). On 2 December it announced a new seven-year CMO contract with a Swiss biotech client worth €20m to produce t...

Agios Pharmaceuticals (AGIO) Presents At 2019 ASH Annual Meeting - Slideshow

Actinium Pharmaceuticals (ATNM) Investor Presentation - Slideshow

Amneal Pharmaceuticals to buy majority stake in AvKARE for $340m

Amneal Pharmaceuticals has agreed to buy a 65.1% stake in pharmaceuticals manufacturer and wholesaler AvKARE and its affiliate R&S Northeast...Read More... The post Amneal Pharmaceuticals to buy majority stake in AvKARE for $340m appeared first on Pharmaceutical Technology.

Regeneron Pharmaceuticals, Inc. Strategy, SWOT and Corporate Finance Report [Report Updated: 04032019] Prices from USD $154

Regeneron Pharmaceuticals, Inc. Strategy, SWOT and Corporate Finance ReportSummaryRegeneron Pharmaceuticals, Inc. Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.Key HighlightsRegenero...


Quick Search

News Quicklinks